The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms

Br J Pharmacol. 2013 Apr;168(8):1961-74. doi: 10.1111/bph.12092.

Abstract

Background and purpose: The transient receptor potential vanilloid type 1 (TRPV1) plays a fundamental role in the detection of heat and inflammatory pain responses. Here we investigated the contribution of two potential endogenous ligands [9- and 13- hydroxyoctadecadienoic acid (HODE)] to TRPV1-mediated noxious responses and inflammatory pain responses.

Experimental approach: 9- and 13-HODE, and their precursor, linoleic acid, were measured in dorsal root ganglion (DRG) neurons and in the hindpaws of control and carrageenan-inflamed rats by liquid chromatography/tandem electrospray mass spectrometry. Calcium imaging studies of DRG neurons were employed to determine the role of TRPV1 in mediating linoleic acid, 9-HODE- and 13-HODE-evoked responses, and the contribution of 15-lipoxygenase to the generation of the HODEs. Behavioural studies investigated the contribution of 9- and 13-HODE and 15-lipoxygenase to inflammatory pain behaviour.

Key results: 9-HODE (35 ± 7 pmol g(-1)) and 13-HODE (32 ± 6 pmol g(-1)) were detected in hindpaw tissue, but were below the limits of detection in DRGs. Following exposure to linoleic acid, 9- and 13-HODE were detected in DRGs and TRPV1 antagonist-sensitive calcium responses evoked, which were blocked by the 15-lipoxygenase inhibitor PD146176 and an anti-13-HODE antibody. Levels of linoleic acid were significantly increased in the carrageenan-inflamed hindpaw (P < 0.05), whereas levels of 9- and 13-HODE were, however, decreased. Intraplantar co-administration of anti-9- and 13-HODE antibodies and treatment with PD146176 significantly (P < 0.01) attenuated carrageenan-induced hyperalgesia.

Conclusions and implications: This study demonstrates that, although 9- and 13-HODE can activate TRPV1 in DRG cell bodies, the evidence for a role of these lipids as endogenous peripheral TRPV1 ligands in a model of inflammatory pain is at best equivocal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonate 15-Lipoxygenase / metabolism
  • Disease Models, Animal
  • Fluorenes / pharmacology
  • Ganglia, Spinal / metabolism*
  • Inflammation / chemically induced*
  • Inflammation / complications
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Linoleic Acids / metabolism
  • Linoleic Acids / pharmacology*
  • Linoleic Acids, Conjugated / metabolism*
  • Male
  • Mice
  • Pain / complications
  • Pain / drug therapy
  • Pain / metabolism*
  • Rats, Sprague-Dawley
  • TRPV Cation Channels / metabolism*

Substances

  • 6,11-dihydro-5-thia-11-aza-benzo(a)-fluorene
  • Fluorenes
  • Linoleic Acids
  • Linoleic Acids, Conjugated
  • TRPV Cation Channels
  • TRPV1 protein, mouse
  • 9-hydroxy-10,12-octadecadienoic acid
  • 13-hydroxy-9,11-octadecadienoic acid
  • Arachidonate 15-Lipoxygenase